|
ZDHHC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5546000042832E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.91469999977612E-07 |
| Normal-vs-Stage2 |
7.64950000000653E-05 |
| Normal-vs-Stage3 |
8.04539999954557E-07 |
| Normal-vs-Stage4 |
8.05329999999937E-05 |
| Stage1-vs-Stage2 |
7.009800E-01 |
| Stage1-vs-Stage3 |
2.798200E-01 |
| Stage1-vs-Stage4 |
1.686850E-01 |
| Stage2-vs-Stage3 |
4.783600E-01 |
| Stage2-vs-Stage4 |
1.728970E-01 |
| Stage3-vs-Stage4 |
4.254200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.42789957214529E-10 |
| Normal-vs-AfricanAmerican |
4.189500E-04 |
| Normal-vs-Asian |
1.026000E-02 |
| Caucasian-vs-AfricanAmerican |
3.297200E-01 |
| Caucasian-vs-Asian |
8.277800E-01 |
| AfricanAmerican-vs-Asian |
6.296200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.89610002646157E-10 |
| Normal-vs-Female |
7.614800E-04 |
| Male-vs-Female |
3.989800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.836570E-03 |
| Normal-vs-Extreme_Weight |
1.80039982922153E-10 |
| Normal-vs-Obese |
4.42289999957879E-07 |
| Normal-vs-Extreme_Obese |
1.541750E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.776560E-01 |
| Normal_Weight-vs-Obese |
6.468600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.443800E-01 |
| Extreme_Weight-vs-Obese |
1.505230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.211000E-01 |
| Obese-vs-Extreme_Obese |
8.610800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.985600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.68289999993954E-07 |
| Normal-vs-Age(61-80Yrs) |
1.86810000024629E-07 |
| Normal-vs-Age(81-100Yrs) |
3.97079999991945E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.892800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.978000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.161020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.824400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.244100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.603700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.37280000003892E-06 |
| Normal-VS-Type2 PRCC |
2.16309999999664E-05 |
| Normal-VS-KIRP CIMP |
2.121500E-02 |
| Normal-VS-Unclassified PRCC |
1.9299499999903E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.337400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.344400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.766000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.263980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.169200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.209800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.27020002585965E-09 |
| Normal-vs-N1 |
4.87710000163233E-08 |
| Normal-vs-N2 |
1.876390E-02 |
| N0-vs-N1 |
9.037800E-01 |
| N0-vs-N2 |
8.731400E-01 |
| N1-vs-N2 |
9.299400E-01 |
|
|
